Yi Zhang
Impact in
- Infectious Diseases top 0.01%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Immunology top 0.05%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 56
- Immunology 321
- Immune Cell Function and Interaction 120
- Immunotherapy and Immune Responses 102
- Immune cells in cancer 71
- Co-authors
- Xiaoying Gu (2 shared papers)Jiuyang Xu (2 shared papers)Yeming Wang (2 shared papers)Bin Cao (2 shared papers)Fei Zhou (2 shared papers)Guohui Fan (2 shared papers)Hui Li (1 shared paper)Shengjin Tu (1 shared paper)
- Journals
- Oncotarget (22 papers)Frontiers in Immunology (20 papers)Cancer Immunology Immunotherapy (18 papers)The Journal of Immunology (18 papers)Frontiers in Oncology (15 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yi Zhang
1.3k papers receiving 57.9k citations
Yi Zhang's Hit Papers
Peers
Comparison fields: 5 of 213
- Infectious Diseases 11.8k
- Immunology 11.8k
- Oncology 11.3k
- Cancer Research 5.9k
- Neurology 5.3k
Countries citing papers authored by Yi Zhang
This map shows the geographic impact of Yi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhang more than expected).
Fields of papers citing papers by Yi Zhang
This network shows the impact of papers produced by Yi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhang. The network helps show where Yi Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.3k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Hit paper breakdown → | 2020 | 18256 |
| 2 | The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer Hit paper breakdown → | 2017 | 2440 |
| 3 | Roles of IFN-γ in tumor progression and regression: a review Hit paper breakdown → | 2020 | 843 |
| 4 | Tumor-associated macrophages: from basic research to clinical application Hit paper breakdown → | 2017 | 680 |
| 5 | COVID-19: immunopathogenesis and Immunotherapeutics Hit paper breakdown → | 2020 | 576 |
| 6 | Biomedical Applications of Zinc Oxide Nanomaterials Hit paper breakdown → | 2013 | 534 |
| 7 | Immunosenescence: molecular mechanisms and diseases Hit paper breakdown → | 2023 | 494 |
| 8 | SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 Hit paper breakdown → | 2020 | 478 |
| 9 | Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation Hit paper breakdown → | 2001 | 439 |
| 10 | Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome Hit paper breakdown → | 2020 | 438 |
| 11 | 2018 | 351 | |
| 12 | 2010 | 345 | |
| 13 | Immunosenescence: a key player in cancer development Hit paper breakdown → | 2020 | 333 |
| 14 | 2006 | 317 | |
| 15 | 2002 | 311 | |
| 16 | Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy Hit paper breakdown → | 2023 | 285 |
| 17 | 2020 | 266 | |
| 18 | 2016 | 253 | |
| 19 | 2006 | 241 | |
| 20 | 1999 | 227 |
About Yi Zhang
Yi Zhang is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Surgery, having authored 1.3k papers that have together received 58.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (120 papers), Immunotherapy and Immune Responses (102 papers), MicroRNA in disease regulation (84 papers), CAR-T cell therapy research (77 papers), Cancer-related molecular mechanisms research (75 papers), Immune cells in cancer (71 papers), Cancer Immunotherapy and Biomarkers (63 papers) and Circular RNAs in diseases (56 papers). The work is most often cited by research in Infectious Diseases (11.8k citations), Immunology (11.8k citations), Oncology (11.3k citations), Cancer Research (5.9k citations) and Neurology (5.3k citations). Yi Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiaoying Gu, Jiuyang Xu, Yeming Wang, Bin Cao, Fei Zhou, Guohui Fan, Hui Li, Shengjin Tu, Bin Song and Zhibo Liu. Their work appears in journals such as Oncotarget, Frontiers in Immunology, Cancer Immunology Immunotherapy, The Journal of Immunology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.